Olanzapin Genericon (Olanzapine)

Olanzapine, the active ingredient in Olanzapin Genericon, is a atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults. GNH USA supplies Olanzapin Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olanzapin Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olanzapine is an atypical antipsychotic that acts on dopamine and serotonin pathways to treat serious mental health conditions.

- Schizophrenia: helps reduce hallucinations, delusions and thought disorder. - Bipolar I disorder (manic episodes): aids the control of elevated mood, agitation and rapid speech. - Bipolar depressive episodes: assists in alleviating depressive symptoms when used as part of combination therapy. - Schizoaffective disorder : improves both psychotic and mood components of the illness. - Maintenance therapy : supports long‑term stability and relapse prevention. - Adjunctive treatment : may be used alongside other psychotropics for treatment‑resistant cases.

Olanzapine may cause a range of adverse reactions, from mild to potentially serious.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hyperglycaemia - Orthostatic hypotension - Elevated prolactin levels - Agranulocytosis 

Olanzapine should be used with careful clinical monitoring and patient education.

- Monitor: regular assessment of weight, glucose and lipid profiles. - Caution: avoid abrupt discontinuation to prevent withdrawal‑rebound rebound re‑ re re  t   t  d \\  \